
Please visit answersincme.com/860/cvdprostate-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Michael Cookson, MD; Alicia Morgans, MD, MPH; and Avirup Guha, MD, MBBS, MPH, FAHA, FACC, FESC, FICOS. In this activity, experts in prostate cancer discuss cardiovascular risk in patients receiving androgen-deprivation therapy (ADT). Upon completion of this activity, participants should be better able to: Evaluate the impacts of prostate cancer and ADT on cardiovascular risk; Translate the latest research for cardiovascular management of patients on ADT to clinical practice; and Design personalized treatment approaches to optimize ADT across treatment settings.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

ADCs in Gynecologic Cancer Care: Enhancing the Patient’s Treatment Journey Through Optimal Adverse Event Management

Adding Multi-Cancer Early Detection to the Primary Care Toolbox: Strategies for Everyday Practice

Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation

Sustaining Long-Term Care With ALK TKIs in Metastatic NSCLC: Best Practices for Adverse Event Management
Free AI-powered recaps of CME in Minutes: Education in Oncology & Hematology and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.